Cargando…

Radiation-induced enterocolitis after combination therapy with palliative radiotherapy and immune checkpoint inhibitors in patients with metastatic lung cancer

The impact of immune checkpoint inhibitors (ICIs) on radiation-induced enterocolitis (RIE) after palliative radiotherapy (PRT) to the bowel has remained to be fully investigated. The aim of the present study was to investigate whether ICIs affect RIE after PRT. For this purpose, 32 lesions (vertebra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Makita, Kenji, Hamamoto, Yasushi, Kanzaki, Hiromitsu, Nagasaki, Kei, Sugawara, Yoshifumi, Ninomiya, Takashi, Harada, Daijiro, Kozuki, Toshiyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8987940/ https://www.ncbi.nlm.nih.gov/pubmed/35401794 http://dx.doi.org/10.3892/etm.2022.11266

Ejemplares similares

An easy tool to predict survival in patients with bone metastatic lung cancer treated with palliative radiotherapy
por: Makita, Kenji, et al.
Publicado: (2023)

Local control of bone metastasis treated with palliative radiotherapy in patients with lung cancer: An observational retrospective cohort study
por: Makita, Kenji, et al.
Publicado: (2023)

Impact of neutrophil-to-lymphocyte ratio throughout the course of chemoradiotherapy on overall survival and distant failure in unresectable stage III non-small cell lung cancer
por: Kanzaki, Hiromitsu, et al.
Publicado: (2021)

Factors affecting local control of bone metastases from radioresistant tumors treated with palliative external beam radiotherapy
por: Makita, Kenji, et al.
Publicado: (2023)

Relationship between seminal vesicle displacement and distribution of hydrogel spacer within the perirectal space in prostate radiotherapy
por: Makita, Kenji, et al.
Publicado: (2023)

Impact of digital positron emission tomography/computed tomography on the delineation of clinical target volume in advanced lung cancer
por: Makita, Kenji, et al.
Publicado: (2023)

Local control after palliative external beam radiotherapy for bone metastases in patients with favorable prognosis
por: Makita, Kenji, et al.
Publicado: (2022)

Prognostic assessment of patients who receive radiotherapy for bone metastases from breast cancer
por: Makita, Kenji, et al.
Publicado: (2023)

Factors Affecting Survival and Local Control in Patients with Bone Metastases Treated with Radiotherapy
por: Makita, Kenji, et al.
Publicado: (2023)

Chemoradiotherapy for Small-Cell Prostate Carcinoma: A Case Report
por: Makita, Kenji, et al.
Publicado: (2023)

Impact of timing of radium‑223 administration on the survival of patients with bone metastatic castration‑resistant prostate cancer
por: Makita, Kenji, et al.
Publicado: (2023)

Local control of bone metastases treated with external beam radiotherapy in recent years: a multicenter retrospective study
por: Makita, Kenji, et al.
Publicado: (2021)

Risk factors for pericardial effusion after chemoradiotherapy for thoracic esophageal cancer—comparison of four-field technique and traditional two opposed fields technique
por: Takata, Noriko, et al.
Publicado: (2018)

Update on Immune Checkpoint Inhibitor Enterocolitis
por: Kelly-Goss, Molly R., et al.
Publicado: (2022)

Severe esophageal stenosis in a patient with metastatic colon cancer following palliative radiotherapy, ramucirumab, and chemotherapy
por: Akahane, Keiko, et al.
Publicado: (2020)

Vedolizumab treatment for immune checkpoint inhibitor-induced enterocolitis
por: Bergqvist, Viktoria, et al.
Publicado: (2017)

Biopsy of palliative lesions following radiotherapy
por: Fujita, Shiro, et al.
Publicado: (2019)

Proton radiotherapy for recurrent or metastatic sarcoma with palliative quad shot
por: Lee, Anna, et al.
Publicado: (2021)

Diagnostic utility of CT for suspected immune checkpoint inhibitor enterocolitis
por: Durbin, Sienna M, et al.
Publicado: (2020)

Docetaxel plus ramucirumab with primary prophylactic pegylated-granulocyte-colony stimulating factor for pretreated non-small cell lung cancer
por: Hata, Akito, et al.
Publicado: (2018)

JME-001 phase II trial of first-line combination chemotherapy with cisplatin, pemetrexed, and nivolumab for unresectable malignant pleural mesothelioma
por: Miyamoto, Yosuke, et al.
Publicado: (2021)

The survival impact of palliative radiotherapy on synchronous metastatic pancreatic ductal adenocarcinoma: metastatic site can serve for radiotherapy-decision
por: Xu, Biaoxiang, et al.
Publicado: (2022)

Palliative radiotherapy in advanced cancer patients treated with immune-checkpoint inhibitors: The PRACTICE study
por: Bersanelli, Melissa, et al.
Publicado: (2020)

Impact of stereotactic body radiotherapy vs palliative radiotherapy on oncologic outcomes of patients with metastatic kidney cancer concomitantly treated with immune checkpoint inhibitors: a preliminary, multicentre experience
por: Francolini, Giulio, et al.
Publicado: (2022)

Palliative radiotherapy
por: Spencer, Katie, et al.
Publicado: (2018)

Palliative radiotherapy in patients with a symptomatic pelvic mass of metastatic colorectal cancer
por: Bae, Sun Hyun, et al.
Publicado: (2011)

Patterns of Palliative Radiotherapy Utilization for Patients With Metastatic Breast Cancer in Harare, Zimbabwe
por: Mushonga, Melinda, et al.
Publicado: (2021)

Crizotinib for recurring non‐small‐cell lung cancer with EML4‐ALK fusion genes previously treated with alectinib: A phase II trial
por: Harada, Daijiro, et al.
Publicado: (2021)

The Synergistic Effect of Immune Checkpoint Blockade and Radiotherapy in Recurrent/Metastatic Sinonasal Cancer
por: Yazici, Gozde, et al.
Publicado: (2018)

The Palliative Care in the Metastatic Spinal Tumors. A Systematic Review on the Radiotherapy and Surgical Perspective
por: Giammalva, Giuseppe Roberto, et al.
Publicado: (2022)

Tofacitinib and faecal microbiota transplantation in treating checkpoint inhibitor-induced enterocolitis: case report
por: Holmstroem, Rikke Boedker, et al.
Publicado: (2022)

Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitis
por: Badran, Yousef R, et al.
Publicado: (2023)

The Role of Abdominal Surgery in Refractory Immune Checkpoint Inhibitor Enterocolitis: A Case Report
por: Verhé, Manon, et al.
Publicado: (2023)

Risk factors for severe gastrointestinal toxicity in patients receiving palliative radiotherapy for metastatic bone tumors: association with the use of molecular-targeted agents
por: Murakami, Yuji, et al.
Publicado: (2020)

The Evolving Practice of Palliative Radiotherapy
por: Rembielak, A., et al.
Publicado: (2020)

Enterocolitis
por: Cobb, O. W.
Publicado: (1906)

Hypofractionated Low-Dose Radiotherapy Combined with Immune Checkpoint Inhibition in Metastatic Solid Tumors
por: Li, Dongqing, et al.
Publicado: (2021)

Risk Factors for Poor Outcome after Palliative Surgery for Metastatic Spinal Tumors
por: Suzuki, Akinobu, et al.
Publicado: (2023)

Dosimetric Modeling of Lymphopenia in Patients With Metastatic Cancer Receiving Palliative Radiation and PD-1 Immune Checkpoint Inhibitors
por: Qian, Jack M., et al.
Publicado: (2021)

Taking the bull by the horn: the frontline use of infliximab for the treatment of immune checkpoint inhibitor-induced enterocolitis
por: Esfahani, Khashayar
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9sk3ofecuv3b087lvd0m0ji2d7